首页> International immunopharmacology> Remimazolam mitigates cerebral ischemia/reperfusion injury by concurrently alleviating damage to the blood-brain barrier and RIP3/MLKL-driven necroptosis.

Remimazolam mitigates cerebral ischemia/reperfusion injury by concurrently alleviating damage to the blood-brain barrier and RIP3/MLKL-driven necroptosis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Zhihui,Wang

第一单位： Department of Anesthesiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu Province 210008, PR China.

作者： Zhihui,Wang ^[1] ; Ruikun,Zhang ^[1] ; Dong,Dai ^[1] ; Meiling,Zhang ^[1] ; Dapeng,Gao ^[1] ; Jie,Zhang ^[1] ; Zhifang,Wu ^[1] ; Kangli,Hui ^[1] ; Jingwei,Xiong ^[1] ; Hao,Cheng ^[2] ; Jiali,Xu ^[3] ; Qing,Ji ^[4]

作者单位： Department of Anesthesiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu Province 210008, PR China. ^[1] Department of Anesthesiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu Province 210008, PR China. Electronic address: chenghao927@126.com. ^[2] Department of Anesthesiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu Province 210008, PR China. Electronic address: xjl15950466318@163.com. ^[3] Department of Anesthesiology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu Province 210008, PR China. Electronic address: qing_ji@nju.edu.cn. ^[4]

关键词 Blood-brain barrier Necroptosis Neuroinflammation Pyroptosis Remimazolam